- 2013
-
Press releases - 21.11.2013
Where and how are fear-related behaviours and anxiety disorders controlled?
A team of researchers at Inserm led by Cyril Herry (Inserm Unit 862, “Neurocentre Magendie,” Bordeaux) has just shown that interneurons located in the forebrain at the level of the prefrontal cortex are heavily involved in the control of fear responses. Using an approach combining in vivo recordings and optogenetic manipulations in mice, the researchers succeeded in showing that the inhibition of parvalbumin-expressing prefrontal interneurons triggers a chain reaction resulting in fear behaviour.
-
Press releases - 18.11.2013
Cancer treatment: a step towards personalized chronotherapy
An international study conducted on mice and coordinated by researchers from Inserm, CNRS and Université Paris-Sud[1] has paved the way towards personalized chronotherapy treatments. In an article published in the journal Cancer Research, the team has shown that the timing of optimal tolerance to irinotecan, a widely used anti-cancer drug, varies by 8 hours depending on the sex and genetic background of mice. They then developed a mathematical model that makes it possible to predict, for each animal, the optimal timing for administering the drug.
-
Press releases - 18.11.2013
Inserm and Fondation ARSEP organize the third meeting between researchers and patients
Multiple Sclerosis (MS) is a debilitating neurological disease which affects 80,000 individuals in France. At the moment, there is no known cause or cure. There are only treatments for the disease symptoms. Given the need to keep patients informed of progress in research, Inserm and Fondation ARSEP organise national meetings between researchers and patients every two years.
-
What's on? - 13.11.2013
An acidic diet may increase the risk of type 2 Diabetes
Diabetes mellitus is characterised by a permanently high level of blood sugar. There are two types, known as type 1 (once known as juvenile diabetes or insulin-dependent diabetes) and type 2 (formerly noninsulin-dependent diabetes mellitus (NIDDM) or adult-onset diabetes, which concerns 90% of diabetics). World Diabetes Day, launched in 2011, will be held on Thursday […]
-
Press releases - 13.11.2013
Launch of third season of GrippeNet.fr
Launched two years ago by the French GPs Sentinelles network (a joint research unit involving Inserm and the Université Pierre et Marie Curie) and the French Institute for Public Health Surveillance, the GrippeNet.fr website is back for a third consecutive year.
-
What's on? - 08.11.2013
12 november: world pneunomia day
Each year, pneumonia kills more than AIDS, malaria and measles combined (according to the UN, 1.2 million children under 5 die of pneumonia each year). Rapid noting of symptoms and quick treatment would avoid many infant deaths. For this World Day, the UN calls upon people to unite against pneumonia, the “leading child killer”. Pneumonia, […]
-
News in brief - 08.11.2013
A disrupted biological clock: a risk factor for anxiety disorders
In mammals, light is essential in order for the body to function properly. This response to light is controlled in our bodies by a biological clock. Like well-oiled clockwork, the central clock located in a small structure of the brain known as the hypothalamus in turn synchronises numerous secondary clocks present in other areas of […]
-
What's on? - 07.11.2013
Take care of your teeth to protect your heart
We already know the importance of a healthy mouth and teeth to prevent tooth decay and avoid gum inflammation. The American researchers showed that the damage done by bacteria is not mainly in the mouth, but spreads throughout the body, deteriorating artery walls. The study, carried out over 3 years on 420 people with an […]
-
What's on? - 05.11.2013
Pollution threatens the health of 2 million people
This Tuesday, environmentalists denounced the various forms of pollution caused by human activity which today threatens the health of millions of people. A list of the ten most polluted places in the world was published. According to the AFP and experts on the question, based on studies carried out in 49 countries, the 10 sites […]
-
Press releases - 04.11.2013
Identification of a new mechanism in the most commonly used immunotherapy for lymphoma
In a lymphoma model, the scientists have been able to carry out real time in vivo imaging of the cellular events activated by the treatment and resulting in the destruction of tumor cells.